Intravenous Magnesium Sulphate versus Dexamethasone during Sevoflurane Anesthesia

Effect Of Intravenous Magnesium Sulphate or Dexamethasone as Adjuvants to Sevoflurane Anesthesia During Primary Cleft Palate Repair

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201601001421209

Enrollment

Registered

2016-01-12

Start date

2014-11-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Interventions

Controlled group (group C)

Magnesium group (group M)

Dexamethasone group (group D)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All children with incomplete cleft palate. 2- 6 years old. ASA I.

Exclusion criteria

Exclusion criteria: Any family history with allergy to dexamethasone or magnesium. Any neurological disease. Any psychological problems. Disagreement of parents.

Design outcomes

Primary

Measure	Time frame
The emergence of delirium was assessed using watcha score	—

Secondary

Measure	Time frame
glucose level. ;Heart rate and blood pressure	—

Countries

Egypt

Contacts

Public ContactSaad Saad

saadibrahim_7@yahoo.com+201223142889

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026